San Anselmo, CA, United States of America

Gene Michal

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gene Michal: Innovator in Drug Delivery Systems

Introduction

Gene Michal is a notable inventor based in San Anselmo, California. He has made significant contributions to the field of drug delivery systems, particularly in the treatment of allergic rhinitis. His innovative approach combines bioresorbable materials with pharmaceutical compositions to enhance therapeutic efficacy.

Latest Patents

Gene Michal holds a patent for an allergic rhinitis drug delivery implant. This invention features a bioresorbable implant designed for use in the nasal region. The implant incorporates one or more bioresorbable polymers, along with a pharmaceutical composition that is coupled to these polymers. The release rate of the pharmaceutical composition is intricately linked to the degradation rate of the bioresorbable polymers, ensuring a controlled and effective delivery of medication.

Career Highlights

Gene Michal is currently associated with Spirox Corporation, where he continues to develop innovative solutions in the medical field. His work focuses on improving patient outcomes through advanced drug delivery technologies. With a patent portfolio that includes 1 patent, he has established himself as a key player in the industry.

Collaborations

Gene has collaborated with talented professionals such as Daniel L. Cox and Piyush Arora. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Gene Michal's contributions to drug delivery systems exemplify the impact of innovation in healthcare. His work not only addresses critical medical needs but also paves the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…